Cotinine (COT) antibody and antigen (hapten, BSA/OVA conjugated)

 Download 

Diagnostic anti-Cotinine (COT) antibodies (anti-Cotinine, anti-COT) and diagnostic hapten-carrier conjugates BSA-Cotinine (COT), OVA-Cotinine (COT), KLH-Cotinine (COT) antigens for Inflammation/autoimmune/inflammatory disease COT detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Go to Inflammation/autoimmune/inflammatory disease diagnostics products collection>>

Product information

Size： 1mg | 10mg | 100mg

Product Description

BSA-Cotinine (COT)

OVA-Cotinine (COT)

Anti-human Cotinine (COT) mouse monoclonal antibody (mAb)

Anti-human Cotinine (COT) human monoclonal antibody (mAb)

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Cotinine and its Significance in In Vitro Diagnosis (IVD): Cotinine, a metabolite of nicotine found in tobacco products, holds significant importance in the realm of in vitro diagnosis (IVD). As a primary target molecule for diagnostic assays, our company specializes in providing anti-Cotinine antibodies and small molecule competitive antigens, including Carrier-coupled antigens, immunogens, hapten-carrier conjugates, Bovine Serum Albumin (BSA)-conjugated, and Ovalbumin (OVA)-conjugated forms. These meticulously engineered reagents are designed to facilitate the precise detection of Cotinine within various sample matrices.

The Imperative of Cotinine Measurement:

a. Tobacco and Nicotine Exposure Assessment: Cotinine serves as a reliable biomarker for evaluating tobacco and nicotine exposure. By quantifying Cotinine levels in bodily fluids like urine or blood, healthcare providers gain insights into an individual's exposure to tobacco smoke or nicotine-containing products. This assessment extends to both active and passive smoke exposure, making it invaluable in clinical and public health settings.

b. Supporting Smoking Cessation Programs: Accurate Cotinine measurements are instrumental in smoking cessation programs. They allow individuals and healthcare professionals to monitor progress towards quitting smoking, tailor interventions, and provide targeted support. By tracking Cotinine levels over time, it becomes possible to gauge the effectiveness of smoking cessation strategies and adjust treatment plans accordingly.

c. Maternal and Fetal Health: In the context of pregnancy, monitoring Cotinine levels is essential to protect maternal and fetal health. Elevated Cotinine levels in pregnant women may indicate active smoking, which can lead to adverse pregnancy outcomes such as preterm birth, low birth weight, and developmental issues. Cotinine testing during pregnancy is a preventive measure to identify and support pregnant individuals who smoke.

d. Occupational and Insurance Screening: Cotinine testing is a common component of occupational health and insurance screening processes. It verifies an individual's tobacco use history, impacting insurance premiums and workplace policies. Employers may use Cotinine tests as part of workplace wellness programs to encourage smoking cessation and promote employee health.

e. Research and Epidemiology: Cotinine assays play a pivotal role in epidemiological studies and research focused on understanding the health effects of tobacco and nicotine exposure. They provide valuable data for public health initiatives and policymaking. Researchers can use Cotinine measurements to explore the associations between smoking, nicotine exposure, and various health outcomes, including cardiovascular disease, respiratory conditions, and cancer.

f. Environmental Exposure Assessment: Cotinine measurements are not limited to tobacco smoke exposure alone. They can also be applied to assess environmental exposure to nicotine and tobacco-related toxins. This is particularly relevant in settings where non-smokers may be exposed to secondhand smoke or other sources of environmental contamination.

In summary, precise Cotinine measurement spans a spectrum of clinical, public health, and research applications. From assessing tobacco exposure and supporting smoking cessation efforts to safeguarding maternal and fetal well-being, informing public health policies, and exploring broader environmental exposures, our specialized anti-Cotinine antibodies and competitive antigens empower accurate Cotinine detection. This, in turn, contributes to enhanced healthcare outcomes, informed policy decisions, and the advancement of scientific knowledge in the field of tobacco and nicotine research.

About GDU